Recall: D-0012-2027

Class II - Potentially Harmful

Class IIClassification
2026-07-29Initiated
OngoingStatus
BioSpectra, Inc.Firm

Product

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Reason

Failed stability specifications

Distribution

CA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.